Search Results - "Schroedter, Mathias"

Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis by Geven, Christopher, Peters, Esther, Schroedter, Mathias, Struck, Joachim, Bergmann, Andreas, McCook, Oscar, Radermacher, Peter, Kox, Matthijs, Pickkers, Peter

“…PURPOSE:Adrenomedullin (ADM) is an important regulator of endothelial barrier function during sepsis. Administration of a murine antibody targeted against the…”
Get full text

Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure by Mebazaa, Alexandre, Laterre, Pierre François, Russell, James A, Bergmann, Andreas, Gattinoni, Luciano, Gayat, Etienne, Harhay, Michael O, Hartmann, Oliver, Hein, Frauke, Kjolbye, Anne Louise, Legrand, Matthieu, Lewis, Roger J, Marshall, John C, Marx, Gernot, Radermacher, Peter, Schroedter, Mathias, Scigalla, Paul, Stough, Wendy Gattis, Struck, Joachim, Van den Berghe, Greet, Yilmaz, Mehmet Birhan, Angus, Derek C

“…Substantial attention and resources have been directed to improving outcomes of patients with critical illnesses, in particular sepsis, but all recent clinical…”
Get full text

Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates by Geven, Christopher, Kox, Matthijs, Blet, Alice, Mebazaa, Alexandre, Schroedter, Mathias, Struck, Joachim, Bergmann, Andreas, Pickkers, Peter

“…Adrenomedullin (ADM) is a vasoactive peptide in sepsis. The non-neutralizing ADM-binding antibody Adrecizumab improved outcome in animal models of systemic…”
Get full text